Mariya Agapova defended by her manager after Maryna Moroz accuses her of being a junkie.

MMA manager Alex Davis defended his client — UFC women’s flyweight Mariya Agapova — after Maryna Moroz accused her of being a junkie.

Mariya recently revealed the bombshell comments about her former training partner at American Top Team as Moroz accused Agapova of threatening behavior at the gym and said she was a drug addict. Agapova is no longer training at American Top Team now she trains at MMA Masters.

Responding to the allegations, Agapova’s manager denied all claims that she is a drug addict, though he admitted that she has dealt with internal struggles.

“Agapova went through some difficult moments. She was all alone (in the United States), but now she’s been through therapy, she’s much better, and she’s already training for a fight. It had nothing to do with drugs. Absolutely nothing,” Davis said.

“This is Mariya’s private life that we’re not going to make an issue to make her private life public.  She came to the states from Kazakhstan, she went through some difficult moments, she had some crises, she got therapy, and she’s doing very, very well now. She’s already training for a fight. There’re no drugs. It has nothing to do with it.”

Agapova (9-2) made her UFC debut in 2020 with a first-round submission win over Hannah Cifers. She was the favorite to win against Shana Dobson in her second UFC fight but lost after she gassed out and was finished in the second round in what was one of the biggest upsets of all time according to the betting odds. That fight was last summer, and we haven’t seen Agapova back in the cage yet, so it will be interesting to see what she looks like in her return.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Sign Up For News

Breaking News And Highlights Around Boxing, MMA, Kickboxing, Martial Arts and more!

By signing up, you agree to comply with our Terms of Service and Privacy Policy.